Global Bordetella Pertussis Nucleic Acid Detection Kit Market Size By Type (Dry PCR, Fluorescence PCR), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2023 to 2032

The Global Bordetella Pertussis Nucleic Acid Detection Kit Market was valued at USD 512 million in 2023 and is projected to reach USD 928 million by 2031, growing at a CAGR of 7.6% during the forecast period from 2023 to 2031. This market is driven by the rising global incidence of whooping cough (pertussis), growing demand for early and accurate diagnostics, and increased awareness of infectious disease control. Nucleic acid detection kits, including PCR-based diagnostics, are crucial tools for identifying Bordetella pertussis rapidly and accurately, especially in clinical settings where time-sensitive diagnosis is key to disease management and outbreak containment.

Drivers:

1. Rising Incidence of Pertussis Worldwide:

The resurgence of whooping cough in several regions due to waning immunity and insufficient vaccination coverage has amplified the need for efficient diagnostic solutions like nucleic acid detection kits.

2. Advancements in Molecular Diagnostics:

The development of high-sensitivity PCR and real-time PCR platforms has enabled rapid detection of Bordetella pertussis, making these kits essential in public health laboratories and hospitals.

3. Government-Led Infectious Disease Control Programs:

Supportive healthcare policies, vaccination surveillance, and funding for infectious disease diagnostics are accelerating the adoption of these kits, particularly in developed and emerging nations.

Restraints:

1. High Cost and Technical Requirements:

Despite their effectiveness, nucleic acid detection kits require sophisticated laboratory infrastructure and trained personnel, limiting widespread adoption in under-resourced settings.

2. Regulatory Complexities:

Stringent approval processes and variations in diagnostic standards across countries can delay product availability and market entry for new players.

Opportunity:

1. Expansion in Emerging Markets:

Rapid improvements in healthcare infrastructure and laboratory capacity in regions like Asia-Pacific and Latin America present growth opportunities for kit manufacturers.

2. Integration of Multiplex Platforms:

The evolution of multiplex diagnostic kits capable of simultaneously detecting multiple respiratory pathogens is expected to create product innovation avenues within the market.

Market by System Type Insights:

Based on system type, Real-time PCR Kits accounted for the largest share of the market in 2023. These kits are favored for their high sensitivity, specificity, and rapid turnaround times. The Isothermal Amplification Kits segment is projected to grow at the fastest pace during the forecast period, owing to their simplified workflows and compatibility with low-resource settings.

Market by End-use Insights:

In terms of end use, Hospitals and Clinical Laboratories dominated the market in 2023, contributing over 50% of total revenue. The increasing burden of respiratory infections and need for hospital-based diagnostics support this dominance. Meanwhile, the Public Health Laboratories segment is expected to exhibit significant growth, driven by increasing surveillance programs and outbreak response initiatives.

Market by Regional Insights:

Geographically, North America led the global market in 2023 due to robust diagnostic infrastructure, high awareness levels, and supportive government funding. Asia-Pacific is expected to witness the highest CAGR during the forecast period, with rising healthcare expenditure, expansion of diagnostic networks, and increasing prevalence of pertussis in countries like India and China.

Competitive Scenario:

Key players operating in the Global Bordetella Pertussis Nucleic Acid Detection Kit Market include:

Bio-Rad Laboratories Inc.

Thermo Fisher Scientific Inc.

Qiagen N.V.

F. Hoffmann-La Roche Ltd.

Luminex Corporation

Takara Bio Inc.

Cepheid (Danaher Corporation)

Seegene Inc.

These companies are focusing on launching new multiplex platforms, gaining regulatory approvals, and expanding into emerging markets. For example:

In 2024, Cepheid launched an updated Xpert® multiplex assay capable of detecting Bordetella pertussis alongside other respiratory pathogens.

In 2023, Qiagen expanded its QIAstat-Dx panel portfolio to include pertussis, targeting hospital-based respiratory diagnostics.

Scope of Work – Global Bordetella Pertussis Nucleic Acid Detection Kit Market

Report Metric Details

Market Size (2023) USD 512 million

Projected Market Size (2031) USD 928 million

CAGR (2023–2031) 7.6%

Market Segments By System Type (Real-time PCR Kits, Isothermal Amplification Kits), End-use (Hospitals, Public Health Labs, Diagnostic Centers), Region

Growth Drivers Rising incidence of pertussis, advancements in molecular diagnostics, government-led disease control efforts

Opportunities Expansion in emerging markets, development of multiplex diagnostic platforms

Key Market Developments:

April 2024: Roche Diagnostics received CE-IVD approval for a new pertussis-specific nucleic acid detection kit tailored for pediatric diagnostics.

November 2023: Seegene Inc. launched a fully automated, high-throughput detection system integrated with AI-based data analysis for respiratory infections including Bordetella pertussis.

March 2023: Thermo Fisher introduced a regional initiative in Southeast Asia to expand access to PCR-based pertussis detection in community health programs.

FAQs:

What is the current market size of the Global Bordetella Pertussis Nucleic Acid Detection Kit Market?

The market was valued at USD 512 million in 2023.

What is the major growth driver of the Global Bordetella Pertussis Nucleic Acid Detection Kit Market?

The major growth driver is the rising incidence of pertussis and increased demand for accurate and rapid diagnostics.

Which is the largest region during the forecast period in the Global Bordetella Pertussis Nucleic Acid Detection Kit Market?

North America held the largest market share in 2023, while Asia-Pacific is expected to grow at the fastest rate.

Which segment accounted for the largest market share in the Global Bordetella Pertussis Nucleic Acid Detection Kit Market?

The Real-time PCR Kits segment accounted for the largest market share in 2023.

Who are the key market players in the Global Bordetella Pertussis Nucleic Acid Detection Kit Market?

Key players include Thermo Fisher Scientific, Qiagen, Bio-Rad Laboratories, Roche, and Cepheid.

Would you like this content in a Word or PDF document format?